Biotech Values

[drbio45]

Medgenics:

Just from that description I would think there are some major issues with regards to scale. That's a 2.5 mL "sliver" that is supposed to produce how many times it's weight in protein *and* guarantee secretion of said protein to the circulation so that it reaches a therapeutic level?

so far everyone that has been given the tissue back has produced the protein for a minimum of six months.


And practically, is this any better for the patient than IV infusion? Or is it just a "novel" way of delivery (scale issues aside)?


If you take interferon as an example you get the flu like symptoms because of the peak effect of the injection then at the end of the week you have a trough in the drug effect then it is time for a new injection.

This process should keep the drug effect level reducing the side effects.


http://www.medgenics.com/downloads/Presentation_Medgenics%20ASN%202010%20.pdf